Nicotinic Acetylcholine Receptor Ligands, a Patent Review (2006-2011)

Overview

Journal Expert Opin Ther Pat

Publisher Informa Healthcare

Date 2011 Nov 22

PMID 22098319

Citations 14

Authors

Daniela Gundisch

Christoph Eibl

Affiliations

Soon will be listed here.

Abstract

Introduction: Nicotinic acetylcholine receptors (nAChRs), pentameric ligand-gated cation channels, are potential targets for the development of therapeutics for a variety of disease states.

Areas Covered: This article is reviewing recent advances in the development of small-molecule ligands for diverse nAChR subtypes and is a continuation of an earlier review in this journal.

Expert Opinion: The development of nAChR ligands with preference for α4β2 or α7 subtypes for the treatment of central nervous system disorders are in the most advanced developmental stage. In addition, there is a fast growing interest to generate so-called PAMs, positive allosteric modulators, to influence the channels' functionalities.

Citing Articles

The Role of the Acetylcholine System in Common Respiratory Diseases and COVID-19.

Li D, Wu J, Xiong X Molecules. 2023; 28(3).

PMID: 36770805 PMC: 9920988. DOI: 10.3390/molecules28031139.

NAChRDB: A Web Resource of Structure-Function Annotations to Unravel the Allostery of Nicotinic Acetylcholine Receptors.

Chareshneu A, Pant P, Tristao Ramos R, Sehnal D, Gokbel T, Ionescu C ACS Omega. 2021; 6(36):23023-23027.

PMID: 34549102 PMC: 8444218. DOI: 10.1021/acsomega.1c00817.

Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Halder N, Lal G Front Immunol. 2021; 12:660342.

PMID: 33936095 PMC: 8082108. DOI: 10.3389/fimmu.2021.660342.

Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives.

Wang M, Gong Y, Yu Z, Tian Y, Zhuo L, Huang W Molecules. 2020; 25(23).

PMID: 33271818 PMC: 7730554. DOI: 10.3390/molecules25235667.

Nicotinic Receptor Subunits Atlas in the Adult Human Lung.

Diabasana Z, Perotin J, Belgacemi R, Ancel J, Mulette P, Delepine G Int J Mol Sci. 2020; 21(20).

PMID: 33050277 PMC: 7588933. DOI: 10.3390/ijms21207446.

References

Wilson G, Karlin A . Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method. Proc Natl Acad Sci U S A. 2001; 98(3):1241-8. PMC: 14739. DOI: 10.1073/pnas.98.3.1241. View

Grottick A, Trube G, Corrigall W, Huwyler J, Malherbe P, Wyler R . Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther. 2000; 294(3):1112-9. View

Freedman R, Leonard S . Genetic linkage to schizophrenia at chromosome 15q14. Am J Med Genet. 2002; 105(8):655-7. DOI: 10.1002/ajmg.1548. View

Dani J, Bertrand D . Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2006; 47:699-729. DOI: 10.1146/annurev.pharmtox.47.120505.105214. View

Corrigall W, Franklin K, Coen K, CLARKE P . The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl). 1992; 107(2-3):285-9. DOI: 10.1007/BF02245149. View

Sine S . The nicotinic receptor ligand binding domain. J Neurobiol. 2002; 53(4):431-46. DOI: 10.1002/neu.10139. View

Freedman R, Hall M, Adler L, Leonard S . Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 1995; 38(1):22-33. DOI: 10.1016/0006-3223(94)00252-X. View

Mineur Y, Picciotto M . Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci. 2010; 31(12):580-6. PMC: 2991594. DOI: 10.1016/j.tips.2010.09.004. View

Lagostena L, Danober L, Challal S, Lestage P, Mocaer E, Trocme-Thibierge C . Modulatory effects of S 38232, a non alpha-7 containing nicotine acetylcholine receptor agonist on network activity in the mouse hippocampus. Neuropharmacology. 2009; 58(4-5):806-15. DOI: 10.1016/j.neuropharm.2009.12.003. View

10.

Guan Z, Zhang X, Ravid R, Nordberg A . Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem. 2000; 74(1):237-43. DOI: 10.1046/j.1471-4159.2000.0740237.x. View

11.

Sharma T, Antonova L . Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am. 2003; 26(1):25-40. DOI: 10.1016/s0193-953x(02)00084-9. View

12.

Papke R, Dwoskin L, Crooks P, Zheng G, Zhang Z, McIntosh J . Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras. Neuropharmacology. 2008; 54(8):1189-200. PMC: 2494738. DOI: 10.1016/j.neuropharm.2008.03.010. View

13.

Anderson D, Malysz J, Gronlien J, El Kouhen R, Hakerud M, Wetterstrand C . Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination. Biochem Pharmacol. 2009; 78(7):844-51. DOI: 10.1016/j.bcp.2009.06.024. View

14.

Yakel J . Gating of nicotinic ACh receptors: latest insights into ligand binding and function. J Physiol. 2009; 588(Pt 4):597-602. PMC: 2828134. DOI: 10.1113/jphysiol.2009.182691. View

15.

Plazas P, Katz E, Gomez-Casati M, Bouzat C, Elgoyhen A . Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor. J Neurosci. 2005; 25(47):10905-12. PMC: 6725887. DOI: 10.1523/JNEUROSCI.3805-05.2005. View

16.

Karlin A . Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002; 3(2):102-14. DOI: 10.1038/nrn731. View

17.

Salminen O, Murphy K, McIntosh J, Drago J, Marks M, Collins A . Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol. 2004; 65(6):1526-35. DOI: 10.1124/mol.65.6.1526. View

18.

Simosky J, Stevens K, Adler L, Freedman R . Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl). 2002; 165(4):386-96. DOI: 10.1007/s00213-002-1285-x. View

19.

Lippiello P, Beaver J, Gatto G, James J, Jordan K, Traina V . TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci Ther. 2008; 14(4):266-77. PMC: 6494058. DOI: 10.1111/j.1755-5949.2008.00054.x. View

20.

Improgo M, Tapper A, Gardner P . Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol. 2011; 82(8):1015-21. DOI: 10.1016/j.bcp.2011.05.020. View